← Back to Screener
MDxHealth SA Ordinary Shares (MDXH)
Price$2.20
Favorite Metrics
Price vs S&P 500 (26W)-52.88%
Price vs S&P 500 (4W)-35.18%
Market Capitalization$114.54M
All Metrics
Book Value / Share (Quarterly)$0.12
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)42.79%
Cash Flow / Share (Quarterly)$-0.07
Price vs S&P 500 (YTD)-37.94%
Gross Margin (TTM)64.54%
Net Profit Margin (TTM)-31.79%
EPS (TTM)$-1.02
10-Day Avg Trading Volume0.27M
EPS Excl Extra (TTM)$-1.02
Revenue Growth (5Y)42.34%
EPS (Annual)$-0.67
ROI (Annual)-50.76%
Gross Margin (Annual)64.55%
Net Profit Margin (5Y Avg)-76.80%
Cash / Share (Quarterly)$0.59
Revenue Growth QoQ (YoY)18.57%
ROA (Last FY)-24.25%
Revenue Growth TTM (YoY)19.82%
EBITD / Share (TTM)$-0.50
ROE (5Y Avg)-376.22%
Operating Margin (TTM)-13.56%
Cash Flow / Share (Annual)$-0.42
P/B Ratio19.19x
P/B Ratio (Quarterly)11.78x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.08x
Net Interest Coverage (TTM)-0.69x
ROA (TTM)-32.86%
EPS Incl Extra (Annual)$-0.67
Current Ratio (Annual)1.56x
Quick Ratio (Quarterly)0.90x
3-Month Avg Trading Volume0.15M
52-Week Price Return48.08%
Revenue / Employee (TTM)$1
P/S Ratio (Annual)1.06x
Asset Turnover (Annual)0.57x
52-Week High$5.33
Operating Margin (5Y Avg)-60.54%
EPS Excl Extra (Annual)$-0.67
CapEx CAGR (5Y)16.46%
26-Week Price Return-48.89%
Quick Ratio (Annual)1.43x
13-Week Price Return-32.65%
Total Debt / Equity (Annual)4.00x
Current Ratio (Quarterly)1.08x
Enterprise Value$172.115
Revenue / Share Growth (5Y)-0.57%
Asset Turnover (TTM)1.03x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)10.50x
Pretax Margin (Annual)-32.79%
Cash / Share (Annual)$0.96
3-Month Return Std Dev59.45%
Gross Margin (5Y Avg)57.37%
Net Income / Employee (TTM)$-0
ROE (Last FY)-253.79%
Net Interest Coverage (Annual)-0.97x
EPS Basic Excl Extra (Annual)$-0.67
Receivables Turnover (TTM)10.96x
Total Debt / Equity (Quarterly)14.07x
EPS Incl Extra (TTM)$-1.02
Receivables Turnover (Annual)6.85x
ROI (TTM)-48.61%
P/S Ratio (TTM)0.72x
Pretax Margin (5Y Avg)-77.06%
Revenue / Share (Annual)$2.16
Price vs S&P 500 (52W)18.25%
Year-to-Date Return-35.29%
5-Day Price Return11.59%
EPS Normalized (Annual)$-0.67
ROA (5Y Avg)-44.62%
Net Profit Margin (Annual)-31.07%
Month-to-Date Return0.43%
EBITD / Share (Annual)$-0.18
Operating Margin (Annual)-13.36%
LT Debt / Equity (Annual)4.93x
ROI (5Y Avg)-81.66%
LT Debt / Equity (Quarterly)12.63x
EPS Basic Excl Extra (TTM)$-1.02
P/B Ratio (Annual)7.82x
Inventory Turnover (TTM)10.67x
Pretax Margin (TTM)-32.87%
Book Value / Share (Annual)$0.31
Price vs S&P 500 (13W)-33.34%
Beta0.90x
Revenue / Share (TTM)$3.11
ROE (TTM)-304.96%
52-Week Low$1.51
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.33
4.33
4.33
4.33
Industry Peers — Health Services(20)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
MDXHMDxHealth SA Ordinary Shares | — | 19.82% | -13.56% | -304.96% | $2.20 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $196.11 |
LHLabcorp Holdings Inc. | 25.08x | 7.25% | 9.92% | 10.28% | $266.36 |
DGXQuest Diagnostics Inc. | 21.24x | 11.78% | 14.10% | 13.88% | $191.46 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $85.70 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $60.09 |
VCYTVeracyte, Inc. | 40.04x | 16.01% | 11.17% | 5.33% | $33.03 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $49.47 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $22.42 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.09 |
About
MDxHealth SA develops molecular diagnostic tests for cancer using proprietary genomic and epigenetic technologies. Its tests help physicians diagnose urologic cancers and predict treatment response and recurrence risk. The company generates revenue through clinical laboratory services and by licensing its DNA methylation platform to partners. It operates in the United States and Europe.